A heparin-binding erythroid cell stimulating factor from fetal bovine serum has the N-terminal sequence of insulin-like growth factor II.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1990-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0006-291X(90)90844-DPMID 2302223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Modeling of Protein‐Glycosaminoglycan Interactions

  1989cited by this paper
• Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long‐term stimulation of plasminogen activator production and DNA synthesis

  1989cited by this paper
• Assay for thymidine incorporation into anchorage dependent or independent cells without filtration or cell harvesting

  1989cited by this paper
• The role of colony stimulating factors, interleukin 1 and stromal extracellular matrix in the regulation of stem cell development.

  1988cited by this paper
• Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form.

  1988cited by this paper
• Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis

  1988cited by this paper
• Cloning, characterization, and expression of a human insulin-like growth factor binding protein.

  1988cited by this paper
• The major erythrotropin of bovine Cohn fraction V has the N-terminal sequence of insulin-like growth factor II with isoleucine at position 35.

  1987cited by this paper
• Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response.

  1987cited by this paper
• New perspectives in cell adhesion: RGD and integrins.

  1987cited by this paper
• Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia

  1987cited by this paper
• Insulin-like growth factors I and II in fetal and adult bovine serum. Purification, primary structures, and immunological cross-reactivities.

  1986cited by this paper
• Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.

  1985cited by this paper
• Extraction from fetal bovine serum of erythrotropin, an erythroid cell-stimulating factor.

  1984cited by this paper
• Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor.

  1984cited by this paper
• Complete amino acid sequence of human plasma beta 2-glycoprotein I.

  1984cited by this paper
• Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin.

  1983cited by this paper
• Tertiary structures, receptor binding, and antigenicity of insulinlike growth factors.

  1983cited by this paper

• Establishment of a feeder and serum-free culture system for human embryonic stem cells

  2020cites this paper
• Heparan sulfate is required for embryonic stem cells to exit from self-renewal.

  2010cites this paper
• Inkjet printing of growth factor concentration gradients and combinatorial arrays immobilized on biologically-relevant substrates.

  2009cites this paper
• Heparan Sulfate Is Required for Embryonic Stem Cells to Exit from Self-renewal*

  2009cites this paper
• Thrombospondin 1, produced by endothelial cells under the action of erythropoietin, stimulates thymidine incorporation into erythroid cells and counteracts the inhibitory action of insulin-like growth factor binding protein 3.

  2005cites this paper
• Purification and characterization of insulin-like growth factor II (IGF II) and an IGF II variant from human placenta.

  1995cites this paper
• Degradation of IGF-I in the adult rat gastrointestinal tract is limited by a specific antiserum or the dietary protein casein.

  1995cites this paper
• Increased heparin binding by site directed mutagenesis of a recombinant chimera of bombyxin and insulin-like growth factor II.

  1995cites this paper
• Glycosaminoglycan binding characteristics of the insulin-like growth factor-binding proteins.

  1994cites this paper
• Insulin-like growth factor I and erythropoiesis.

  1992cites this paper
• Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.

  1992cites this paper
• Nucleotide sequence of the central coding region of bovine erythrotropin/insulin-like growth factor II cDNA from fetal intestine and northern analysis of the major IGF II transcripts at the time of hepatic erythropoiesis.

  1992cites this paper
• Production of growth factors from the human carcinoma cell line, RPMI 2650

  1992cites this paper
• Induction of circulating neonatal stem cell populations.

  1991cites this paper
• HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function.

  1991cites this paper
• On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.

  1991cites this paper
• Heparin augments osteoclast resorption‐stimulating activity in serum

  1991cites this paper
• Isolation from fetal bovine serum of an apolipoprotein-H-like protein which inhibits thymidine incorporation in fetal calf erythroid cells.

  1990cites this paper